APA (7th ed.) Citation

Center for Biologics Evaluation and Research (U.S.). (2006). Guidance for industry: Supplemental guidance on testing for replication competent retrovirus in reroviral vector based gene therapy products and during follow-up of patients in clinical trials using retroviral vectors. U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research.

Chicago Style (17th ed.) Citation

Center for Biologics Evaluation and Research (U.S.). Guidance for Industry: Supplemental Guidance on Testing for Replication Competent Retrovirus in Reroviral Vector Based Gene Therapy Products and During Follow-up of Patients in Clinical Trials Using Retroviral Vectors. Rockville, MD: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, 2006.

MLA (9th ed.) Citation

Center for Biologics Evaluation and Research (U.S.). Guidance for Industry: Supplemental Guidance on Testing for Replication Competent Retrovirus in Reroviral Vector Based Gene Therapy Products and During Follow-up of Patients in Clinical Trials Using Retroviral Vectors. U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, 2006.